2 unknown, 1 active not recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Active not recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Ochsner Health System: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD Autologous mononuclear cells - Congenital Heart Disease, SRV Dependent | Phase 1 | Active not recruiting | Timothy J Nelson, MD, PhD | 30 | 2021-06-01 | 2025-06-27 |
| 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography. - Neuroendocrine, Neuroendocrine Tumor | Phase 1 / Phase 2 | Unknown | Ochsner Health System | 250 | 2014-03-01 | 2014-01-17 |
| Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer Endoscopic Bipolar RadioFrequency Probe used to remove tumors in bile duct to manage Pancreatic Cancer - Pancreatic Cancer | Phase 1 | Unknown | Ochsner Health System | 40 | 2013-02-01 | 2014-01-23 |
Adenoma, Islet Cell (1) · Apudoma (1) · Carcinoid Tumor (1) · Carcinoma, Neuroendocrine (1) · Heart Defects, Congenital (1) · Hypoplastic Left Heart Syndrome (1) · Neuroendocrine Tumors (1) · Pancreatic Neoplasms (1)
United States (2)
Benjamin Peeler, MD (1) · David M Overman (1) · Harold M Burkhart (1) · James Jaggers, MD (1) · James Tweddell, M.D. (1) · Jason Maynes, MD (1) · John D Cleveland, MD (1) · Joseph Dearani (1) · Waldemer Carlo, M.D. (1)